George Magrath insider trades: Opus Genetics (IRD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where George reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | IRD | ↓ Sell | 28,258 | $3.90 | $110K | Direct | Nov 5, 2026 (2d) |
| Oct 23, 2026 | IRD | ↓ Sell | 9,591 | $3.58 | $34K | Direct | Oct 27, 2026 (4d) |
| Mar 16, 2026 | IRD | ↓ Sell | 24,438 | $5.21 | $127K | Direct | Mar 18, 2026 (2d) |
| Dec 26, 2024 | IRD | ↑ Buy | 100,000 | $0.98 | $98K | Direct | Dec 30, 2024 (4d) |
| Nov 18, 2024 | IRD | ↑ Buy | 100,000 | $1.01 | $101K | Direct | Nov 19, 2024 (1d) |
| May 17, 2024 | OCUP | ↑ Buy | 5,000 | $1.75 | $9K | Direct | May 21, 2024 (4d) |
| Mar 18, 2024 | OCUP | ↑ Buy | 25,000 | $1.96 | $49K | Direct | Mar 20, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRD insiders
Open-market trades in the last 12 months
About George Magrath's insider trades
George Magrath is Chief Executive Officer at Opus Genetics (IRD). Since Mar 18, 2024, George has reported 4 open-market purchases worth $257K and 3 sales worth $272K on SEC Form 4. In the last 12 months: 3 sales ($272K).
Their filings also include grants and awards (5 filings), shares withheld for taxes (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.